The US Food and Drug Administration wants to withdraw approval of an Amgen drug after years on the market over alleged data manipulation, according to Bloomberg.
Amgen is defending the drug.
FDA Seeks to Withdraw Amgen Drug Approval Over Alleged Data Manipulation
2026-06-25 09:48:54
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
